AmerisourceBergen Drug Corporation Sustainability Profile
AmerisourceBergen Drug Corporation, commonly referred to as AmerisourceBergen, is a leading global healthcare solutions provider headquartered in the United States. Founded in 2001, the company has established itself as a key player in the pharmaceutical distribution industry, serving healthcare providers across North America and beyond. Specialising in pharmaceutical distribution, AmerisourceBergen offers a comprehensive range of services, including supply chain management, logistics, and consulting. The company is renowned for its commitment to improving patient access to medications and enhancing the efficiency of healthcare delivery. With a strong market position, AmerisourceBergen has achieved significant milestones, including strategic partnerships and innovative solutions that set it apart in the competitive landscape.
DitchCarbon Score
How does AmerisourceBergen Drug Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AmerisourceBergen Drug Corporation's score of 39 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AmerisourceBergen Drug Corporation's reported carbon emissions
In 2021, AmerisourceBergen Drug Corporation reported significant carbon emissions, totalling approximately 112,936,750 kg CO2e for Scope 1 and 96,472,630 kg CO2e for Scope 2 on a global scale. In the United States, the emissions were approximately 21,309,311 kg CO2e for Scope 1 and about 66,627,361 kg CO2e for Scope 2. The company did not disclose any Scope 3 emissions data for that year. AmerisourceBergen's emissions data is cascaded from its parent company, Cencora, Inc., which is responsible for the reporting of these figures. Despite the substantial emissions, there are currently no specific reduction targets or climate pledges outlined in their initiatives. The company is actively engaged in climate commitments, although specific reduction initiatives or targets have not been detailed. As a current subsidiary of Cencora, Inc., AmerisourceBergen's climate strategy may align with broader corporate sustainability goals, but further information is needed to assess their specific commitments and performance in reducing carbon emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Scope 1 | 109,727,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 105,581,090 | 00,000,000 | 00,000,000 |
| Scope 3 | 19,532,581,490 | - | 00,000,000,000 |
How Carbon Intensive is AmerisourceBergen Drug Corporation's Industry?
How Carbon Intensive is AmerisourceBergen Drug Corporation's Location?
AmerisourceBergen Drug Corporation's Scope 3 Categories Breakdown
AmerisourceBergen Drug Corporation's Scope 3 emissions, which increased by 14% last year and increased by approximately 14% since 2019, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 95% of Scope 3 emissions.
Top Scope 3 Categories
AmerisourceBergen Drug Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AmerisourceBergen Drug Corporation has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Walgreens Boots Alliance
Cencosud
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.